Share
6,783 Posts.
lightbulb Created with Sketch. 4491
clock Created with Sketch. 21/10/22
14:52
Share
Originally posted by Outlander2
↑
Hi Bavarianand very expensive ) Phase III trials.access toclinical drug supplies which match and pair the clinical trial developmentplans with the regulatory requirements of phase II/III andregistrational trials is a critical component of drug development .”Phase II/III clinical trials , NOT Phase III.may allow research questions to be answered more quickly or with fewer patients (thus much, much cheaper, and now with the additional funding, within the reach of IMU). They may also beregistrational !!! This, as I read it, is what they are saying.bigger news than many realise , although I’m very happy to consider other views.
Expand
In my humble opinion, you nailed it. Be it from the personnel or funding or supply point of view, IMU is setting up for a big period of growth. There is no ifs or buts about it. Just a matter of process now.
(20min delay)